ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker"
Episode Synopsis
Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2.
Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker.
Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker.
Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
In God we trust